What Is the Difference Between ADPKD and ARPKD Conditions?

Autosomal Dominant Polycystic Kidney Disease (ADPKD) and Autosomal Recessive Polycystic Kidney Disease (ARPKD) are two distinct genetic conditions that can cause cystic changes and enlarged kidneys, with timing and severity varying widely ^[1]. While they share a similar name, they are driven by different gene changes, are inherited differently, and usually begin at very different stages of life ^[2]. Age alone does not establish a diagnosis; doctors use a combination of clinical symptoms, medical imaging, family history, and sometimes genetic testing to determine which condition a person has ^[3].

At a Glance: ADPKD vs. ARPKD

Genetic Differences and Inheritance

The primary difference between the two diseases lies in how they are inherited and which genes are involved:

• ADPKD (Autosomal Dominant): This form is usually caused by a genetic change (mutation) in either the PKD1 or PKD2 gene ^[4]. “Autosomal dominant” means that you only need to inherit the altered gene from one parent to develop the condition. If one parent has ADPKD, each child has a 50% chance of inheriting the gene ^[4]. Note that a negative family history does not rule out ADPKD, as new, spontaneous gene changes can occur ^[5].
• ARPKD (Autosomal Recessive): This form is classically linked to changes in the PKHD1 gene (though other genes can sometimes be involved) ^[6]. “Autosomal recessive” means a child must inherit an altered copy of the gene from both parents. Parents who each carry one copy of the recessive gene usually do not have the disease themselves, but they have a 25% chance of passing the condition to each child ^[6].

Kidney Changes and Age of Onset

The structural changes in the kidneys, as well as the timeline for when the disease is detected, differ significantly between the two conditions, though both have variable outcomes ^[5][3]:

• ADPKD Morphology and Timing: ADPKD is characterized by the progressive growth of larger fluid-filled cysts over decades ^[1]. Often called “adult-onset” PKD, an individual may have no physical symptoms for many years while cysts grow and blood pressure changes are monitored by a doctor. A decline in kidney function is a clinical measure that usually becomes apparent between the ages of 30 and 50, but disease severity varies widely ^[7]. Some individuals maintain normal kidney function for many years, while others progress to chronic kidney disease. In some cases, ADPKD can present very early in life, even before birth ^[8].
• ARPKD Morphology and Timing: ARPKD is primarily a ductal-plate malformation that causes the kidney’s collecting ducts to dilate, resulting in numerous microscopic or small cystic changes rather than large cysts ^[2]. Often called “infantile” PKD, severe cases may be detected prenatally on an ultrasound ^[9]. However, many children are diagnosed after birth, and individuals with milder ARPKD-associated gene changes may not be diagnosed until their juvenile or adult years ^[6].

Shared Risks and Different Extrarenal Complications

Both conditions can eventually reduce kidney function and share one major risk factor: high blood pressure (hypertension). High blood pressure is highly prevalent and can occur early in life in both ADPKD and ARPKD, making regular blood-pressure monitoring a critical shared requirement ^[10][11].

Beyond the kidneys, the conditions affect other organs—referred to as extrarenal manifestations—in very different ways ^[11].

ARPKD: Liver Fibrosis and Early Severity

Severe prenatal or neonatal ARPKD can impact a baby’s lung development and early kidney function ^[2]. Outside of the kidneys, the hallmark complication of ARPKD is congenital hepatic fibrosis—a developmental abnormality where scar tissue builds up in the liver ^[12]. Depending on its severity, this may lead to portal hypertension, which is increased pressure in the vein system that carries blood from the digestive organs to the liver ^[12]. Another related liver issue in the ARPKD spectrum is Caroli disease, which involves the widening of the bile ducts in the liver and can cause recurrent infections and stones ^[13][14].

ADPKD: Cysts, Aneurysms, and Heart Health

ADPKD typically progresses more slowly. Liver involvement is also very common in ADPKD, but it usually manifests as liver cysts (polycystic liver disease) rather than the severe liver scarring seen in ARPKD ^[15].

Furthermore, ADPKD has specific cardiovascular and vascular risks that require different monitoring:

• Intracranial Aneurysms: People with ADPKD have an increased risk of developing weakened, bulging blood vessels in the brain (aneurysms). In one presymptomatic screening cohort, aneurysms were detected in about 9% of people with ADPKD ^[16]. Screening is not automatically recommended for everyone; it is highly individualized and usually discussed if you have a family history of aneurysms or subarachnoid hemorrhage (bleeding around the brain), high blood pressure, or a history of smoking ^[17]. Note: A sudden “worst-ever” severe headache, new weakness, confusion, trouble speaking, or loss of consciousness are medical emergencies and require immediate emergency care.
• Cardiovascular Issues: ADPKD can be associated with heart valve defects and aortic root dilation (a widening of the main artery carrying blood from the heart) ^[18]. Heart imaging is ordered by your doctor only when clinically appropriate.

Understanding which form of PKD you or your child has is critical, as it changes the genetic counseling for your family, the screening tools your doctor will use, and the specific complications you need to monitor.